AI brief of an SEC Form 8-K · Medical Properties Trust (MPT)

Medical Properties Trust Q2 net loss narrows to $98 million; NFFO falls to $81 million

Mixed Impact 3 of 5 earnings Written later

Medical Properties Trust reported a second-quarter 2025 net loss of $98 million ($0.16 per share), smaller than the $321 million ($0.54 per share) loss a year earlier. Normalized funds from operations (NFFO) fell to $81 million ($0.14 per share) from $139 million ($0.23 per share), and total revenues declined to $240.4 million from $266.6 million, so shareholders see a smaller loss alongside weaker operating measures.

Key points

  • Net loss of $98 million ($0.16 per share) for Q2 2025 vs. $321 million ($0.54 per share) in Q2 2024; the quarter includes about $111 million ($0.18 per share) in impairment and fair market value adjustments.
  • NFFO of $81 million ($0.14 per share) vs. $139 million ($0.23 per share) a year earlier; total revenues were $240.4 million vs. $266.6 million.
  • Cash rental income from new tenants rose to $11.0 million from $3.4 million in Q1 2025; scheduled third-quarter cash collections approximate $17 million.
  • A regular quarterly dividend of $0.08 per share was paid in July 2025.

The filing

CompanyMedical Properties Trust (MPT)
Form8-K, current report
Filed with the SECJul 31, 2025, 8:30 AM ET
Accession number0001193125-25-170123

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 6:59 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on July 31, 2025.

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.